Michael Willem Waters - 30 Aug 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
30 Aug 2024
Net transactions value
-$30,218
Form type
4
Filing time
04 Sep 2024, 16:11:51 UTC
Previous filing
05 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +2,113 +2.8% 76,327 30 Aug 2024 Direct F1
transaction TDOC Common Stock Options Exercise +6,200 +8.1% 82,527 30 Aug 2024 Direct F2
transaction TDOC Common Stock Sale $30,218 -4,218 -5.1% $7.16 78,309 03 Sep 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Options Exercise $0 -2,113 -14% $0.000000 12,679 30 Aug 2024 Common Stock 2,113 Direct F1, F4
transaction TDOC Restricted Stock Units Options Exercise $0 -6,200 -14% $0.000000 37,204 30 Aug 2024 Common Stock 6,200 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 On March 3, 2023, the reporting person was granted 74,405 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.